Delonix Bioworks
PrivateLast Round
Seed
Mar 11, 2021
Total Funding Raised
$14M
Company Overview
Delonix Bioworks is a biotechnology company that develops next-generation genetically engineered bacterial vaccines using its proprietary OMV Plus platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Delonix Bioworks Comparables
Compare Delonix Bioworks with similar companies based on industry and business-model similarity.
Delonix Bioworks Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 11, 2021 |
Delonix Bioworks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Seed |
| ZhenFund | Seed |
| Boehringer Ingelheim Venture Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 8, 2025
Collaborating with Olymvax to accelerate next-generation pertussis vaccines.
- Mar 11, 2021
$14M round led by Boehringer Ingelheim Venture Fund and IDG Capital.
Delonix Bioworks Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Delonix Bioworks's valuation, stock price, and market status.